Skip to main content Skip to footer

Improving Biotherapeutic Analysis With an Inert Flow Path

Tuesday, October 13, 2026
8am PDT | 11am EDT | 4pm BST | 5pm CEST

Biotherapeutic analyses can be impacted by nonspecific interactions with metal surfaces, resulting in reduced recovery, peak tailing, and compromised quantitation. In this webinar, learn how an inert flow path approach, including Agilent Altura Ultra Inert column technology, minimizes adsorption and improves chromatographic performance for peptides and proteins, including mAbs, ADCs, and GLP-1 therapeutics. Application data will be highlighted to demonstrate improved aggregate analysis, enhanced peak shape, and greater method-development flexibility across SEC and RP-HPLC workflows. Discover practical strategies to achieve more reliable, sensitive, and reproducible biopharmaceutical analyses.

 

Topics include:

  • How metal surfaces impact biomolecule separations
  • How improving flow path inertness can improve peak shape and analyte recovery
  • Optimizing SEC methods for biotherapeutic characterization

Speakers

 

Dr. Anne Blackwell (Product Manager Bio LC Columns, Agilent Technologies)

Anne is a product manger for bio LC columns at Agilent, with previous experience as a product support scientist for bio LC columns and an LC/MS applications scientist focused on metabolomics.  She has a Ph.D. in analytical chemistry from the University of Arizona where she studied mass spectrometry of non-covalent protein assemblies.

Dr. Daniel Meston (Application Development Scientist, Agilent Technologies)

Daniel Meston, completed his Ph.D. in bioanalytical chemistry, focusing on the LC/MS-based analysis of T-cell activation at the Helmholtz Centre for Infection Research in 2016. He has spent 10 years researching the fundamental mechanisms that underpin bioseparation performance and advancing 2D-LC/MS-based methods for the analysis of biotherapeutics. Since joining Agilent in 2026, he has worked as an LC/MS applications chemist for BioHPLC columns, developing applications for novel biotherapeutics and further improving bioseparation performance within the Agilent portfolio.

You are already a member of CHROMacademy.
Please sign in to pre-populate the form and register for the webcast.

You are already registered for this webcast.
Please sign in to enter the webcast lobby.

Complete this form to register for the webcast and receive free Lite membership to CHROMacademy

Already registered?

(* indicates required field)

If you are having trouble registering for or viewing this webcast, please contact us

Terms and conditions

By registering for this event, you agree to MJH Life Sciences® Terms and Conditions, Privacy Policy, and understand your data will be used by MJH and its affiliates for amongst other things, alerting you to other services or products that you may be interested in, and may be shared with or sold to third parties for their use, including possible contact with you through email or other communications, consistent with their respective privacy policy. If you do not agree to have your data used in this way, please contact [email protected]. By receiving FREE Lite membership to CHROMacademy, you agree to the CHROMacademy Terms and Conditions and Privacy Policy, as well as confirming you are OK with CHROMacademy emailing you about your membership and FREE to access content; including the CHROMacademy newsletter, webcasts, and promotions.

For full details of how Agilent will treat your information please click here to view our privacy policy.